Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-03

Clinical Trial Update: Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the efficacy of Yinzhihuang Oral Liquid on indirect bilirubin levels in neonates with Glucose-6-phosphate dehydrogenase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yinzhihuang Oral Liquid

Snippet

Sponsor: Southern Medical University, China | Conditions: Neonatal Hyperbilirubinemia | Phase 4 | Status: UNKNOWN